27 May, 2017
The biotechnology company reported ($0.10) earnings per share for the quarter. EPS breaks down the profitability of the company on a single share basis.
Shares of CytRx Corporation (NASDAQ:CYTR) are experiencing unusual volume during today's trading. The last session's volume of 17.73 million shares was higher than its average volume of 8.41 million shares.
CytRx Corporation closed its last trading session at $0.5 with the gain of 20.72%. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
CytRx Corporation (CYTR) has a market capitalization of 92.57 Million which suggests the company is a huge company further suggesting that the shares of CytRx Corporation (CYTR) are stable and safe compared to the lower market capitalization companies.
Some buy side analysts are also providing their Analysis on CytRx Corporation, where 0 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 0 said it's a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. The stock appeared -81.42% below its 52-week highs and is up 21.76% for the last five trades. Based on an average daily trading volume, of 3,397,304 shares, the short-interest ratio is presently 3.1 days. (NASDAQ:AMZN) a mean recommendation of 1.90. Over the past month the firm's stock is -41.02%, 18.19% for the last quarter, -13.05% for the past six-months and -81.86% for the previous year. The stock's 50 day moving average is $0.52 and its 200-day moving average is $0.47. The day's total volume of 16803247 this morning is in contrast from the three-month daily average of 4635.40K. Company shares have been seen trading -78.62% off of the 52 week high and 94.04% away from the 52 week low. Its last 5-Year EPS growth stands at -20.80% with earnings growth of 128.70% yoy. Alpha One also gave press coverage about the biotechnology company an impact score of 88 out of 100, meaning that recent media coverage is very likely to have an impact on the stock's share price in the near term. Likewise, the negative performance for the quarter was recorded as -10.66% and for the year was -19.90%, while the YTD performance remained at -19.21%.